Breast Neoplasms: all 12,815 studies
Page 128 of 129. Open to participants first (2,920), then studies with results posted, then the rest; newest registration first within each.
- Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticCompletedNCT00003440Phase 3
- Immunotherapy in Treating Patients With Metastatic Breast CancerTerminatedNCT00003432Phase 1/2
- Hormone Therapy in Treating Women With Breast CancerCompletedNCT00003428Phase 2
- Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectCompletedNCT00003425Phase 1/2
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast CancerStatus unknownNCT00003418Phase 3
- Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell TransplantationStatus unknownNCT00003412Phase 1
- High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast CancerCompletedNCT00003392Phase 2
- Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of DiseaseCompletedNCT00003357Phase 1
- Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00003352Phase 2
- Irinotecan in Treating Patients With Refractory Metastatic Breast CancerCompletedNCT00003351Phase 2
- Identification of Genes Associated With Cancer in Patients and Siblings Who Have CancerCompletedNCT00003329
- MRI to Detect Breast Tumors in WomenCompletedNCT00003302Not applicable
- Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00003269Phase 2
- Evaluation of Drug Resistance in Patients With Metastatic Breast CancerStatus unknownNCT00003253Phase 2
- Chemotherapy in Treating Women With Previously Treated Metastatic Breast CancerCompletedNCT00003236Phase 2
- Perillyl Alcohol in Treating Patients With Metastatic Breast CancerCompletedNCT00003219Phase 2
- Bryostatin 1 in Treating Patients With Stage IV Breast CancerCompletedNCT00003205Phase 2
- Vaccine Therapy in Treating Women With Metastatic Breast CancerCompletedNCT00003184Phase 1
- Doxorubicin in Treating Women With Advanced Breast CancerStatus unknownNCT00003165Phase 2
- Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerCompletedNCT00003162Phase 3
- Letrozole After Tamoxifen in Treating Women With Breast CancerCompletedNCT00003140Phase 3
- Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical CancerStatus unknownNCT00003135Phase 2
- Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsCompletedNCT00003125Phase 2
- Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsCompletedNCT00003107Phase 1
- Chemotherapy in Treating Patients With Solid TumorsCompletedNCT00003103Phase 1/2
- Chemoprevention Therapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003099Phase 2
- Diet and Estrogen Metabolism in Postmenopausal WomenCompletedNCT00003098Not applicable
- S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast CancerCompletedNCT00003095
- Combination Chemotherapy in Treating Patients With Breast CancerCompletedNCT00003088Phase 3
- Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast CancerTerminatedNCT00003086Phase 1/2
- High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast CancerCompletedNCT00003068Phase 2
- Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast CancerStatus unknownNCT00003066Phase 2
- Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast CancerCompletedNCT00003050Phase 2
- Pyrazoloacridine in Treating Women With Refractory Metastatic Breast CancerCompletedNCT00003041Phase 2
- Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid TumorsCompletedNCT00003038Phase 1
- Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast CancerCompletedNCT00003035Phase 2
- High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00003032Phase 3
- Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast CancerStatus unknownNCT00003016Phase 3
- Chemotherapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003013Phase 3
- Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast CancerCompletedNCT00003012Phase 3
- Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following ChemotherapyCompletedNCT00003010Phase 3
- HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerCompletedNCT00003002Phase 1
- Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00002998Phase 2
- Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast CancerCompletedNCT00002967Phase 3
- Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast CancerCompletedNCT00002953Phase 3
- Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast CancerCompletedNCT00002942Phase 3
- Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast CancerCompletedNCT00002937Phase 2
- Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In SituTerminatedNCT00002934Phase 2
- S9630, Medroxyprogesterone in Treating Women With Breast CancerCompletedNCT00002920Phase 3
- Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionCompletedNCT00002901Phase 1
- SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical TrialCompletedNCT00002900
- Radiation Therapy in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00002873Phase 1/2
- High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00002870Phase 3
- Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast CancerCompletedNCT00002866Phase 1
- Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00002864Phase 3
- Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically RemovedStatus unknownNCT00002851Phase 3
- High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast CancerCompletedNCT00002837Phase 1/2
- Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast CancerCompletedNCT00002836Phase 3
- Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00002826Phase 2
- High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast CancerCompletedNCT00002784Phase 3
- Biological Therapy in Treating Women With Metastatic Breast CancerStatus unknownNCT00002780Phase 1/2
- Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00002777Phase 3
- S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast CancerTerminatedNCT00002772Phase 3
- Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast CancerCompletedNCT00002762
- Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast CancerCompletedNCT00002755Phase 3
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast CancerCompletedNCT00002720Phase 3
- Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically RemovedCompletedNCT00002707Phase 3
- Combination Chemotherapy in Treating Women With Stage III Breast CancerSuspendedNCT00002696Phase 3
- Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast CancerCompletedNCT00002680Phase 2
- Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast CancerCompletedNCT00002679Phase 2
- Pain Control in Patients With Recurrent or Metastatic Breast or Prostate CancerTerminatedNCT00002668Not applicable
- Paclitaxel or Docetaxel in Treating Women With Advanced Breast CancerCompletedNCT00002662Phase 3
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast CancerCompletedNCT00002646Phase 3
- Tamoxifen for the Prevention of Breast Cancer in High-Risk WomenCompletedNCT00002644Phase 3
- Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast CancerStatus unknownNCT00002628Phase 1/2
- Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast CancerStatus unknownNCT00002627Phase 1/2
- Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerStatus unknownNCT00002616Phase 1
- Pyrazoloacridine in Treating Women With Metastatic Breast CancerCompletedNCT00002585Phase 2
- Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00002582Phase 3
- Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast CancerCompletedNCT00002581Phase 3
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast CancerCompletedNCT00002580Phase 3
- Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast CancerCompletedNCT00002579Phase 3
- Nutrition Intervention in Treating Women With Breast CancerCompletedNCT00002564Phase 3
- Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast CancerCompletedNCT00002544Phase 3
- Tamoxifen in Treating Women With High-Risk Breast CancerCompletedNCT00002542Phase 3
- Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerCompletedNCT00002529Phase 3
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast CancerCompletedNCT00002528Phase 3
- Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerCompletedNCT00002520Not applicable
- High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast CancerCompletedNCT00002509Phase 1/2
- Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast CancerStatus unknownNCT00002498Phase 2
- Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerCompletedNCT00002475Phase 2
- High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or MesotheliomaStatus unknownNCT00002465Phase 1/2
- Adjuvant Hormone Therapy in Treating Women With Operable Breast CancerStatus unknownNCT00002460Phase 3
- Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or MelanomaStatus unknownNCT00002455Phase 3
- Microarray Analysis for Human Genetic DiseaseCompletedNCT00001898
- Effects of Raloxifene on the Uterus and Ovaries of Premenopausal PatientsCompletedNCT00001837
- Methods in Education for Breast Cancer GeneticsCompletedNCT00001806Phase 3
- A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
- Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast CancerCompletedNCT00001507Phase 1
- A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer PatientsCompletedNCT00001504Phase 1